Gilead Sciences, Inc.
NON-CODING IMMUNOMODULATORY DNA CONSTRUCT
Last updated:
Abstract:
The present invention relates to a nucleic acid molecule and its use for the modulation of the immune system. It provides a DNA construct for immunomodulation comprising at least one nucleotide in L-conformation.
Status:
Application
Type:
Utility
Filling date:
11 Sep 2020
Issue date:
4 Nov 2021